David Sinclair insider trades: Sirtris Pharmaceuticals (SIRT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 11, 2008 | SIRT | ↓ Sell | 7,971 | $13.10 | $104K | Direct | Apr 15, 2008 (4d) |
| Apr 11, 2008 | SIRT | ↓ Sell | 2,129 | $13.42 | $29K | Direct | Apr 15, 2008 (4d) |
| Apr 10, 2008 | SIRT | ↓ Sell | 9,900 | $13.27 | $131K | Direct | Apr 14, 2008 (4d) |
| Jan 10, 2008 | SIRT | ↓ Sell | 10,000 | $13.87 | $139K | Direct | Jan 14, 2008 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David Sinclair's insider trades
David Sinclair is a director at Sirtris Pharmaceuticals (SIRT). Since Jan 10, 2008, David has reported no open-market purchases and 4 sales worth $403K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares returned to the company (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SIRT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.